References
- Azuma K, Inoue S. (2004). [Hormone replacement therapy]. Clin Calcium, 14:153–164.
- Farris C Jr. (2004). Women’s health and hormone replacement therapy. South Med J, 97:1143.
- Kanaoka Y, Honda K, Ishiko O, Hirai K, Ogita S. (2003). Long-term effects of hormone replacement therapy on bone mineral density in girls oophorectomized in adolescence. Gynecol Obstet Invest, 55:168–172.
- Levine JP. (2003). Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis. Curr Womens Health Rep, 3:181–186.
- Steel SA, Albertazzi P, Howarth EM, Purdie DW. (2003). Factors affecting long-term adherence to hormone replacement therapy after screening for osteoporosis. Climacteric, 6:96–103.
- Deady J. (2004). Clinical monograph: hormone replacement therapy. J Manag Care Pharm, 10:33–47.
- Yoo JW, Lee CH. (2006). Drug delivery systems for hormone therapy. J Control Release, 112:1–14.
- Upadhyay KK, Tiwari C, Khopade AJ, Bohidar HB, Jain SK. (2007). Sorbitan ester organogels for transdermal delivery of sumatriptan. Drug Dev Ind Pharm, 33:617–625.
- Kang L, Liu XY, Sawant PD, Ho PC, Chan YW, Chan SY. (2005). SMGA gels for the skin permeation of haloperidol. J Control Release, 106:88–98.
- Lim PF, Liu XY, Kang L, Ho PC, Chan YW, Chan SY. (2006). Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol. Int J Pharm, 311:157–164.
- Moniruzzaman M, Sundararajan PR. (2005). Low molecular weight organogels based on long-chain carbamates. Langmuir, 21:3802–3807.
- Pénzes T, Blazsó G, Aigner Z, Falkay G, Eros I. (2005). Topical absorption of piroxicam from organogels–in vitro and in vivo correlations. Int J Pharm, 298:47–54.
- Vintiloiu A, Lafleur M, Bastiat G, Leroux JC. (2008). In situ-forming oleogel implant for rivastigmine delivery. Pharm Res, 25:845–852.
- Vintiloiu A, Leroux JC. (2008). Organogels and their use in drug delivery – a review. J Control Release, 125:179–192.
- Ruiz MA, Clares B, Morales ME, Gallardo V. (2008). Vesicular lipidic systems, liposomes, PLO, and liposomes-PLO: characterization by electronic transmission microscopy. Drug Dev Ind Pharm, 34:1269–1276.
- Wang K, Jia Q, Han F, Liu H, Li S. (2010). Self-assembled l-alanine derivative organogel as in situ drug delivery implant: characterization, biodegradability, and biocompatibility. Drug Dev Ind Pharm, 36:1511–1521.
- Couffin-Hoarau AC, Motulsky A, Delmas P, Leroux JC. (2004). In situ-forming pharmaceutical organogels based on the self-assembly of l-alanine derivatives. Pharm Res, 21:454–457.
- Luo X, Liu B, Liang Y. (2001). Self-assembled organogels formed by mono-chain l-alanine derivatives. Chem Commun (Camb), 7:1556–1557.
- Wang Y, Tang L, Yu J. (2008). Investigation on the assembled structure-property correlation of supramolecular hydrogel formed from low-molecular-weight gelator. J Colloid Interface Sci, 319:357–364.
- George M, Snyder SL, Terech P, Glinka CJ, Weiss RG. (2003). N-alkyl perfluoroalkanamides as low molecular-mass organogelators. J Am Chem Soc, 125:10275–10283.
- Nahata T, Saini TR. (2008). Optimization of formulation variables for the development of long acting microsphere based depot injection of olanzapine. J Microencapsul, 25:426–433.
- Miyazaki Y, Yakou S, Yanagawa F, Takayama K. (2008). Evaluation and optimization of preparative variables for controlled-release floatable microspheres prepared by poor solvent addition method. Drug Dev Ind Pharm, 34:1238–1245.
- De Smedt SC, Dekeyser P, Ribitsch V, Lauwers A, Demeester J. (1993). Viscoelastic and transient network properties of hyaluronic acid as a function of the concentration. Biorheology, 30:31–41.
- Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 60:110–111.
- Tsai YH, Fu LT, Huang CT, Chang JS, Huang YB, Wu PC. (2011). Formulation optimization of estradiol microemulsion using response surface methodology. J Pharm Sci,100:4383–4389.
- Dabhi M, Gohel M, Parikh R, Sheth N, Nagori S. (2011). Formulation development of ambroxol hydrochloride soft gel with application of statistical experimental design and response surface methodology. PDA J Pharm Sci Technol, 65:20–31.
- Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN. (2007). Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release, 119:77–85.